JDD Buzz | Cutaneous Adverse Events of GLP-1 Agonists
GLP-1 receptor agonists are an increasingly popular treatment for type 2 diabetes and obesity. Additionally, some dermatologists are finding success with treating psoriasis and hidradenitis suppurativa with GLP-1s independent of an impact on weight loss. As GLP-1 use becomes even more common in medicine, it’s important to understand side effects, including skin effects that could lead GLP-1 pati …
GLP-1 receptor agonists are an increasingly popular treatment for type 2 diabetes and obesity. Additionally, some dermatologists are finding success with treating psoriasis and hidradenitis suppurativa with GLP-1s independent of an impact on weight loss. As GLP-1 use becomes even more common in medicine, it’s important to understand side effects, including skin effects that could lead GLP-1 pati … Continue reading "JDD Buzz | Cutaneous Adverse Events of GLP-1 Agonists"
Welcome to "JDD January 2026 Issue Highlights," your guided tour through this month's must-read studies, curated by the Journal of Drugs in Dermatology Editorial Team. This issue carries a Special Focus on Aesthetic Treatments, bringing together practical safety analyses, regulatory perspectives on regenerative medicine, advances in pigmentary and procedural care, and health‑equity research that …